Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 1
1992 2
1993 1
1996 1
1997 5
1998 2
1999 1
2000 1
2001 4
2002 2
2003 2
2004 2
2005 1
2006 2
2007 1
2008 2
2010 3
2011 3
2012 4
2013 2
2014 5
2015 3
2016 1
2017 4
2018 6
2019 4
2020 6
2021 10
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

72 results
Results by year
Filters applied: . Clear all
Page 1
In Regard to Buchsbaum et al.
Breneman J, Perentesis JP, Bradley J, Mascia A, Abel E, Sharda A, Khuntia D, Sharma RA, Simone CB 2nd. Breneman J, et al. Among authors: perentesis jp. Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1544-1545. doi: 10.1016/j.ijrobp.2021.03.034. Epub 2021 Mar 26. Int J Radiat Oncol Biol Phys. 2021. PMID: 33775856 No abstract available.
Toxicity of Cancer Therapy in Adolescents and Young Adults (AYAs).
Bukowinski AJ, Burns KC, Parsons K, Perentesis JP, O'Brien MM. Bukowinski AJ, et al. Among authors: perentesis jp. Semin Oncol Nurs. 2015 Aug;31(3):216-26. doi: 10.1016/j.soncn.2015.05.003. Epub 2015 May 7. Semin Oncol Nurs. 2015. PMID: 26210200 Review.
Proton therapy for pediatric malignancies: Fact, figures and costs. A joint consensus statement from the pediatric subcommittee of PTCOG, PROS and EPTN.
Weber DC, Habrand JL, Hoppe BS, Hill Kayser C, Laack NN, Langendijk JA, MacDonald SM, McGovern SL, Pater L, Perentesis JP, Thariat J, Timmerman B, Yock TI, Mahajan A. Weber DC, et al. Among authors: perentesis jp. Radiother Oncol. 2018 Jul;128(1):44-55. doi: 10.1016/j.radonc.2018.05.020. Epub 2018 Jun 21. Radiother Oncol. 2018. PMID: 29937209 Review.
Children's Oncology Group's 2013 blueprint for research: acute myeloid leukemia.
Gamis AS, Alonzo TA, Perentesis JP, Meshinchi S; COG Acute Myeloid Leukemia Committee. Gamis AS, et al. Among authors: perentesis jp. Pediatr Blood Cancer. 2013 Jun;60(6):964-71. doi: 10.1002/pbc.24432. Epub 2012 Dec 19. Pediatr Blood Cancer. 2013. PMID: 23255301 Free PMC article. Review.
Visual outcomes following everolimus targeted therapy for neurofibromatosis type 1-associated optic pathway gliomas in children.
Ullrich NJ, Prabhu SP, Packer RJ, Goldman S, Robison NJ, Allen JC, Viskochil DH, Gutmann DH, Perentesis JP, Korf BR, Fisher MJ, Kieran MW; NF Clinical Trials Consortium. Ullrich NJ, et al. Among authors: perentesis jp. Pediatr Blood Cancer. 2021 Apr;68(4):e28833. doi: 10.1002/pbc.28833. Epub 2020 Dec 18. Pediatr Blood Cancer. 2021. PMID: 33336845 Clinical Trial.
Targeting AML-associated FLT3 mutations with a type I kinase inhibitor.
Jones LM, Melgar K, Bolanos L, Hueneman K, Walker MM, Jiang JK, Wilson KM, Zhang X, Shen J, Jiang F, Sutter P, Wang A, Xu X, Tawa GJ, Hoyt SB, Wunderlich M, O'Brien E, Perentesis JP, Starczynowski DT, Thomas CJ. Jones LM, et al. Among authors: perentesis jp. J Clin Invest. 2020 Apr 1;130(4):2017-2023. doi: 10.1172/JCI127907. J Clin Invest. 2020. PMID: 32149729 Free PMC article.
Improved chemotherapy modeling with RAG-based immune deficient mice.
Wunderlich M, Manning N, Sexton C, Sabulski A, Byerly L, O'Brien E, Perentesis JP, Mizukawa B, Mulloy JC. Wunderlich M, et al. Among authors: perentesis jp. PLoS One. 2019 Nov 20;14(11):e0225532. doi: 10.1371/journal.pone.0225532. eCollection 2019. PLoS One. 2019. PMID: 31747424 Free PMC article.
72 results